Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Deferred Income Tax
kr347k
CAGR 3-Years
-37%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Deferred Income Tax
kr15.2m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Deferred Income Tax
kr1B
CAGR 3-Years
317%
CAGR 5-Years
107%
CAGR 10-Years
51%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Deferred Income Tax
kr6.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Deferred Income Tax
kr12.4m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.94 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Deferred Income Tax?
Deferred Income Tax
347k SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Deferred Income Tax amounts to 347k SEK.

What is Vicore Pharma Holding AB's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
-29%

Over the last year, the Deferred Income Tax growth was -54%. The average annual Deferred Income Tax growth rates for Vicore Pharma Holding AB have been -37% over the past three years , -29% over the past five years .

Back to Top